Schmitz and co-workers demonstrated that injection of IL-33 into mice induced a profound eosinophilia with associated pathologic changes [50], and had potent effects on eosinophil, including the induced production of superoxide anion and IL-8, degranulation and eosinophil survival [51]. The gene discussed is IL33; the disease is Increased total eosinophil count.